Recent Finacing
Recent Raise
Rgenix is a clinical-stage biopharmaceutical using a miRNA-based target discovery platform to develop RGX-104 (LXR/ApoE immunomodulator) and RGX-202 metabolic-pathway inhibitor in early clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Inspirna.
